Magnetic labeling of activated microglia in experimental gliomas.

Microglia, as intrinsic immunoeffector cells of the central nervous system (CNS), play a very sensitive, crucial role in the response to almost any brain pathology where they are activated to a phagocytic state. Based on the characteristic features of activated microglia, we investigated whether these cells can be visualized with magnetic resonance imaging (MRI) using ultrasmall superparamagnetic iron oxides (USPIOs). The hypothesis of this study was that MR microglia visualization could not only reveal the extent of the tumor, but also allow for assessing the status of immunologic defense. Using USPIOs in cell culture experiments and in a rat glioma model, we showed that microglia can be labeled magnetically. Labeled microglia are detected by confocal microscopy within and around tumors in a typical border-like pattern. Quantitative in vitro studies revealed that microglia internalize amounts of USPIOs that are significantly higher than those incorporated by tumor cells and astrocytes. Labeled microglia can be detected and quantified with MRI in cell phantoms, and the extent of the tumor can be seen in glioma-bearing rats in vivo. We conclude that magnetic labeling of microglia provides a potential tool for MRI of gliomas, which reflects tumor morphology precisely. Furthermore, the results suggest that MRI may yield functional data on the immunologic reaction of the CNS.

[1]  W. Streit,et al.  The brain's immune system. , 1995, Scientific American.

[2]  M. Weller,et al.  Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration , 1999, Journal of Neuroimmunology.

[3]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[4]  Simon R. Cherry,et al.  In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET) , 2000, Nature Biotechnology.

[5]  A J Colon MR findings of the brain stem in arterial hypertension. , 2000, AJNR. American journal of neuroradiology.

[6]  B. Badie,et al.  Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.

[7]  Chien Ho,et al.  Intracellular labeling of T‐cells with superparamagnetic contrast agents , 1993, Magnetic resonance in medicine.

[8]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R Weissleder,et al.  Near-infrared optical imaging of protease activity for tumor detection. , 1999, Radiology.

[10]  R. Morantz,et al.  Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. , 1979, Journal of the National Cancer Institute.

[11]  R. Weissleder Molecular imaging: exploring the next frontier. , 1999, Radiology.

[12]  W. Paulus,et al.  Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.

[13]  P. Rieckmann,et al.  Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.

[14]  Donald S. Williams,et al.  Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.

[15]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[16]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[17]  R. Weissleder,et al.  Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro , 1995, Investigative radiology.

[18]  R. Weissleder,et al.  Tumor Cell Endocytosis Imaging Facilitates Delineation of the Glioma–Brain Interface , 1997, Experimental Neurology.

[19]  J A Frank,et al.  Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide. , 2000, AJNR. American journal of neuroradiology.

[20]  S. Cherry,et al.  Quantification of target gene expression by imaging reporter gene expression in living animals , 2000, Nature Medicine.

[21]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[22]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[23]  Michael Schroeter,et al.  Inflammation and glial responses in ischemic brain lesions , 1998, Progress in Neurobiology.

[24]  R. Tanaka,et al.  Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation , 2000, Journal of Neuroimmunology.

[25]  K. Frei,et al.  Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. , 1986, Journal of immunology.

[26]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[27]  Streit Wj Cellular immune response in brain tumors. , 1994 .

[28]  B Quesson,et al.  In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance , 1999, Magnetic resonance in medicine.

[29]  G. Johnson,et al.  Magnetic Resonance Microscopy of the C57BL Mouse Brain , 2000, NeuroImage.

[30]  T. Möller,et al.  Phagocytozing ameboid microglial cells studied in a mouse corpus callosum slice preparation , 1996, Glia.

[31]  T. Möller,et al.  Microglial phagocytosis is modulated by pro‐and anti‐inflammatory cytokines , 1997, Neuroreport.

[32]  W Semmler,et al.  Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.

[33]  W. Streit,et al.  Microglial Response to Brain Injury: A Brief Synopsis , 2000, Toxicologic pathology.

[34]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C Zimmer,et al.  Cerebral iron oxide distribution: in vivo mapping with MR imaging. , 1995, Radiology.

[36]  C Delalande,et al.  Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. , 1999, AJNR. American journal of neuroradiology.

[37]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[38]  C Zimmer,et al.  MR imaging of phagocytosis in experimental gliomas. , 1995, Radiology.

[39]  S S Gambhir,et al.  High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Black,et al.  Response of microglial cells to experimental rat glioma , 1992, Glia.

[41]  R. Weissleder,et al.  Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.

[42]  R B Banati,et al.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.

[43]  B. Badie,et al.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.

[44]  G A Johnson,et al.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Go,et al.  Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain. , 1993, European journal of radiology.

[46]  R. Jain,et al.  Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. , 1998, BioTechniques.

[47]  D Giulian,et al.  Characterization of ameboid microglia isolated from developing mammalian brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  J. Tonn,et al.  Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. , 1997, Anticancer research.

[49]  J. Moffett,et al.  Quinolinate Immunoreactivity in Experimental Rat Brain Tumors Is Present in Macrophages but Not in Astrocytes , 1997, Experimental Neurology.

[50]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[51]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Steinman,et al.  ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging , 2000, Journal of Neuroimmunology.

[53]  J. Bulte,et al.  Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation , 1998, Journal of Neuroscience Research.

[54]  R Weissleder,et al.  The development of in vivo imaging systems to study gene expression. , 1998, Trends in biotechnology.

[55]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.